Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Pharmacol Res. 2017 Aug 18;128:73–79. doi: 10.1016/j.phrs.2017.08.007

Table 2.

Differentially expressed lncRNAs and their role in OA pathogenesis

Target lncRNA Expression in OA Molecular effects in OA References
HOTAIR Upregulation ECM degradation, Apoptosis, [49] [50]
GAS5 Upregulation ECM degradation, Apoptosis [49]
PCGEM1 Upregulation Apoptosis [51]
HOTTIP Upregulation ECM degradation [52]
LncRNA-CIR Upregulation ECM degradation [48]
H19 Downregulation ECM degradation [49]
MEG3 Downregulation Angiogenesis [53]
CILinc01 Downregulation Inflammation [54]
CILinc02 Downregulation Inflammation [54]
HHS Vulnerability Disclosure